Furthermore, culture-based methods are often associated with significant delays, and while advancements like MALDI-TOF have facilitated bacterial ... The prepared target plate was then inserted into ...

DeutEx is now integrated into the Bruker proteomics ecosystem to support timsTOF, MRMS and MALDI-TOF systems. Dr. Petr Novák, the Head of Structural Biology and Cell Signaling in the Institute of ...

Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 ... microbiology and infection diagnostics driven by both the MALDI Biotyper and the newly acquired ELITech Molecular ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications. All that is missing are your ...

The results demonstrate the effectiveness and versatility of the SUGA method, its equivalence to MALDI-TOF analysis, and its suitability for unbiased glycosylation inhibitor screening. The screening ...